Michael Ryskin
Stock Analyst at B of A Securities
(1.51)
# 3,482
Out of 5,022 analysts
38
Total ratings
54.17%
Success rate
-0.85%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Buy | $110 → $99 | $91.14 | +8.62% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $89.87 | -22.11% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $636.91 | -25.42% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.23 | +147.68% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $129.79 | +58.72% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $62.56 | -36.06% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $3.08 | +208.44% | 1 | Jun 25, 2024 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $11.90 | +101.68% | 2 | Aug 15, 2023 | |
| AVTR Avantor | Maintains: Buy | $27 → $24 | $13.91 | +72.54% | 2 | Jul 31, 2023 | |
| ZTS Zoetis | Maintains: Buy | $225 → $180 | $143.46 | +25.47% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.89 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $80 → $52 | $19.43 | +167.63% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $3.90 | +156.41% | 2 | Nov 10, 2021 |
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $91.14
Upside: +8.62%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $89.87
Upside: -22.11%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $636.91
Upside: -25.42%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.23
Upside: +147.68%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $129.79
Upside: +58.72%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $62.56
Upside: -36.06%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $3.08
Upside: +208.44%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $11.90
Upside: +101.68%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $13.91
Upside: +72.54%
Zoetis
Nov 4, 2022
Maintains: Buy
Price Target: $225 → $180
Current: $143.46
Upside: +25.47%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $5.89
Upside: -
Nov 11, 2021
Downgrades: Neutral
Price Target: $80 → $52
Current: $19.43
Upside: +167.63%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $3.90
Upside: +156.41%